Document is current

Article History

Received: 22 May 2025

Accepted: 18 August 2025

First Online: 29 September 2025

Declarations

:

: The study was approved by the appropriate legal and ethical authorities (ethics committee, Outre-Mer III, #2017-A03491-52). Written informed consent was obtained from next of kin before the inclusion. The study was registered on Clinicaltrials.gov on 12 September 2017 before the inclusion of the first patient (#NCT03281473).

: Not applicable.

: LP reports payments for travel expenses and/or lectures fees from Getinge, Air Liquide Medical Systems, Hamilton Medical, GE Healthcare, Löwenstein, and Fisher and Paykel and consultant fees from Lungpacer and Getinge. JCR reports part-time salary for research activities from Air Liquide Medical Systems and Vygon and grants from Creative Air Liquide, outside this work. AM reports personal fees from Faron Pharmaceuticals, Air Liquid Medical Systems, Pfizer, Resmed and Draeger and grants and personal fees from Fisher and Paykel and Covidien, outside this work. FB reports consulting fees from Löwenstein Medical and Air Liquide Medical Systems and research support from Covidien and GE Healthcare, outside this work. The other authors have no conflict of interest to declare.